The scale of the undertaking reflects how fragmented this evidence base has been. Following the PRISMA reporting guidelines and preregistered in the PROSPERO database under registration CRD42024581685, the research team searched MEDLINE via Ovid, Embase, PsycINFO and Google Scholar using combinations of subject headings, keywords and synonyms for the concepts of adolescents, young adults, substance use disorders and co-occurring mental health conditions. From 1,882 records identified, just 29 studies met the inclusion criteria. That funnel — nearly two thousand papers narrowing to fewer than thirty that passed rigorous screening — says something important in itself: for a population where substance use and psychiatric illness so often travel together, directly relevant, well-conducted research remains surprisingly thin.

Why does this intersection matter so much clinically? The neuroscience offers part of the answer. The adolescent brain undergoes prolonged remodeling, with prefrontal cortical circuits responsible for impulse control and decision-making maturing well into the mid-twenties while subcortical reward and emotion systems develop earlier. Introducing psychoactive substances during this period can interact with these developmental trajectories, and psychiatric symptoms such as depression, anxiety or trauma responses can both drive self-medication with drugs and alcohol and be exacerbated by them. The result is a bidirectional tangle in which it is often impossible to say which problem came first — and in which treating one while ignoring the other frequently fails.

The review’s methodological approach acknowledges precisely this complexity. Because the included studies varied so widely in the populations they examined, the settings where data were collected, the denominators they used and the ways co-occurring conditions were ascertained, the authors chose a narrative synthesis rather than attempting a meta-analysis. That decision is scientifically honest. Pooling prevalence estimates from a school-based survey, an emergency department sample and a residential treatment cohort would produce numbers that look precise but mean little. Instead, the team mapped the patterns that recur across heterogeneous designs — and those patterns proved remarkably consistent.

Across the 29 studies, four broad clusters of mental health presentation appeared most often alongside substance-related problems: depressive conditions, anxiety-related conditions, trauma-related conditions and externalizing disorders, the latter encompassing problems such as conduct and attention-regulation difficulties that manifest in impulsive or disruptive behavior. The recurrence of these clusters across different populations and methods suggests they are not artifacts of any single study’s sampling strategy. For clinicians, the implication is that any young person presenting with a substance-related concern should be understood as carrying an elevated likelihood of one or more of these psychiatric conditions, and vice versa.

Perhaps the most sobering recurring theme was trauma. Exposure to traumatic events, adverse childhood experiences and wider social adversity were commonly reported in association with substance-related problems throughout the reviewed literature. This aligns with a large body of work linking early adversity to both altered stress physiology and later substance use, but the review’s contribution is to show how consistently these factors appear specifically in North American studies of people aged 25 and under. Social adversity — poverty, unstable housing, discrimination and disrupted family environments — is not background noise in this literature; it is entangled with the clinical presentations themselves.

Yet the review also exposes a critical gap between describing the problem and knowing how to treat it. Care-related implications in the included studies were limited, and were largely derived from future-directions statements rather than from direct evaluations of youth-specific service models. In other words, researchers have documented the co-occurrence of substance use and mental health conditions in young North Americans many times over, but surprisingly few studies have actually tested whether integrated, developmentally appropriate programs work better than conventional parallel care. The authors conclude that direct evidence for evaluated, integrated, youth-specific care models remains limited — a finding that will frustrate clinicians and policymakers who need more than intuition to justify investment.

Despite that evidentiary gap, the review’s conclusions point in a clear direction. The authors state that their findings support the relevance of developmentally appropriate, integrated and trauma-informed approaches to care. Trauma-informed care, in practical terms, means services that recognize how common trauma exposure is among young people with substance-related problems, that avoid re-traumatization during assessment and treatment, and that treat safety, trust and choice as clinical priorities rather than soft ideals. Integrated care means bringing psychiatric and addiction treatment under one roof, or at least into tightly coordinated teams, so that a 19-year-old with depression and cannabis use disorder is not shuttled between adult addiction services and child mental health clinics that do not communicate.

The geographic and demographic framing of the review also deserves attention. North America — encompassing the United States and Canada — carries a distinctive burden in this domain, shaped by the opioid crisis, widespread cannabis legalization, high childhood adversity rates in certain communities and stark inequities in access to care. Focusing on people aged 25 and under is developmentally justified: it spans the period of peak onset for both substance use disorders and many psychiatric conditions, and it captures the transition from pediatric to adult services, which is precisely where continuity of care most often breaks down. Studies in the review came from high-risk and service-engaged populations, meaning young people already in contact with treatment systems, emergency settings or other high-acuity contexts — groups where co-occurrence is expected to be most pronounced.

What should readers take away from this work? First, that co-occurring substance use and mental health conditions are not an edge case in adolescent medicine; they are the expected pattern in the populations where clinicians most often encounter these problems. Second, that trauma and social adversity are so pervasive in this literature that any service design which ignores them is likely to fall short. Third, and perhaps most urgent, that the research community has accumulated a great deal of descriptive evidence while leaving the intervention question dangerously underexplored. The authors explicitly call for further research directly evaluating improved service delivery models for this population. With 29 studies distilled from nearly 1,900 records, the review functions both as a map of what is known and as an indictment of what has not been tested — and for the millions of young North Americans navigating mental illness and substance use simultaneously, turning that map into working models of care is the challenge that now defines the field.

Subject of Research: Co-occurring substance use and mental health conditions among adolescents and young adults in North America

Article Title: Substance use and co-occurring mental health conditions among adolescents and young adults in North America: a systematic review

Article References: Kuriakose, G., Seo, J., Asgharipourzahmati, N., Lew, A., Daswani, R., Ignaszewski, M. J., Sassi, R., Choi, F., Seethapathy, V., & Krausz, R. M. (2026). Substance use and co-occurring mental health conditions among adolescents and young adults in North America: a systematic review. BMC Psychiatry, 26(1), Article 703. https://doi.org/10.1186/s12888-026-08580-2

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08580-2

Keywords: substance use, co-occurring mental health conditions, adolescents, young adults, systematic review, trauma, adverse childhood experiences, integrated care, trauma-informed care, BMC Psychiatry, North America, public health